Celecoxib for Stage III Colon Cancer

被引：9

作者：

Kerr, David J. ^{[1
]}

Chamberlain, Sarah ^{[2
]}

Kerr, Rachel S. ^{[3
]}

机构：

[1] Univ Oxford, Dept Med, Oxford, England

[2] Oxford Univ Hosp Trust, Oxford, England

[3] Univ Oxford, Dept Oncol, Oxford, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2021年 / 325卷 / 13期

关键词：

COLORECTAL-CANCER; PIK3CA MUTATION; ASPIRIN USE;

D O I：

10.1001/jama.2021.2651

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1257 / 1258

页数：2

共 13 条

[1] Celecoxib for the prevention of colorectal adenomatous polyps
Arber, Nadir
Eagle, Craig J.
Spicak, Julius
Racz, Istvan
Dite, Petr
Hajer, Jan
Zavoral, Miroslav
Lechuga, Maria J.
Gerletti, Paola
Tang, Jie
Rosenstein, Rebecca B.
Macdonald, Katie
Bhadra, Pritha
Fowler, Robert
Wittes, Janet
Zauber, Ann G.
Solomon, Scott D.
Levin, Bernard
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) : 885 - 895
[2] Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Chan, Andrew T.
Ogino, Shuji
Fuchs, Charles S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (21) : 2131 - 2142
[3] Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
Chan, Andrew T.
Arber, Nadir
Burn, John
Chia, Whay Kuang
Elwood, Peter
Hull, Mark A.
Logan, Richard F.
Rothwell, Peter M.
Schroer, Karsten
Baron, John A.
[J]. CANCER PREVENTION RESEARCH, 2012, 5 (02) : 164 - 178
[4] Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Chan, Andrew T.
Ogino, Shuji
Fuchs, Charles S.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (06): : 649 - 659
[5] Efficacy and Safety Profile of Celecoxib for Treating Advanced Cancers: A Meta-analysis of 11 Randomized Clinical Trials
Chen, Jian
Shen, Peng
Zhang, Xiao-chen
Zhao, Meng-dan
Zhang, Xing-guo
Yang, Liu
[J]. CLINICAL THERAPEUTICS, 2014, 36 (08) : 1253 - 1263
[6] Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
Domingo, Enric
Church, David N.
Sieber, Oliver
Ramamoorthy, Rajarajan
Yanagisawa, Yoko
Johnstone, Elaine
Davidson, Brian
Kerr, David J.
Tomlinson, Ian P. M.
Midgley, Rachel
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4297 - U34
[7] Immunotherapy in colorectal cancer: rationale, challenges and potential
Ganesh, Karuna
Stadler, Zsofia K.
Cercek, Andrea
Mendelsohn, Robin B.
Shia, Jinru
Segal, Neil H.
Diaz, Luis A., Jr.
[J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (06) : 361 - 375
[8] Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Grothey, A.
Sobrero, A. F.
Shields, A. F.
Yoshino, T.
Paul, J.
Taieb, J.
Souglakos, J.
Shi, Q.
Kerr, R.
Labianca, R.
Meyerhardt, J. A.
Vernerey, D.
Yamanaka, T.
Boukovinas, I.
Meyers, J. P.
Renfro, L. A.
Niedzwiecki, D.
Watanabe, T.
Torri, V.
Saunders, M.
Sargent, D. J.
Andre, T.
Iveson, T.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13) : 1177 - 1188
[9] Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, Xiaoyun
Lochhead, Paul
Nishihara, Reiko
Morikawa, Teppei
Kuchiba, Aya
Yamauchi, Mai
Imamura, Yu
Qian, Zhi Rong
Baba, Yoshifumi
Shima, Kaori
Sun, Ruifang
Nosho, Katsuhiko
Meyerhardt, Jeffrey A.
Giovannucci, Edward
Fuchs, Charles S.
Chan, Andrew T.
Ogino, Shuji
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17) : 1596 - 1606
[10] Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial
Meyerhardt, Jeffrey A.
Shi, Qian
Fuchs, Charles S.
Meyer, Jeffrey
Niedzwiecki, Donna
Zemla, Tyler
Kumthekar, Priya
Guthrie, Katherine A.
Couture, Felix
Kuebler, Philip
Bendell, Johanna C.
Kumar, Pankaj
Lewis, Dequincy
Tan, Benjamin
Bertagnolli, Monica
Grothey, Axel
Hochster, Howard S.
Goldberg, Richard M.
Venook, Alan
Blanke, Charles
O'Reilly, Eileen M.
Shields, Anthony F.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1277 - 1285

← 1 2 →